2023 Q1 Communicable Disease Report
SUMMARY OF SELECTED REPORTABLE DISEASES Jan-March 2023
Case counts refer to confirmed and probable cases 1,2,3
|
|
Jan-March 2023 |
Jan-March 2022 |
5-year Median Jan-March |
|
VACCINE PREVENTABLE DISEASES |
|
|
|
|
Haemophilus influenzae, invasive disease |
0 |
1 |
1 |
|
Influenza virus |
724 |
705 |
705 |
|
Measles |
0 |
0 |
0 |
|
Meningococcal invasive disease |
0 |
0 |
0 |
|
Mumps |
0 |
0 |
0 |
|
Novel Coronavirus3 |
1296 |
17612 |
8667 |
|
Pertussis |
3 |
0 |
1 |
|
ENTERIC DISEASES: |
|
|
|
|
Amebiasis |
0 |
0 |
0 |
|
Campylobacteriosis |
6 |
10 |
11 |
|
Cryptosporidiosis |
0 |
1 |
1 |
|
Escherichia coli, Shiga toxin-producing |
2 |
0 |
0 |
|
Giardiasis |
1 |
0 |
0 |
|
Listeriosis |
0 |
0 |
0 |
|
Salmonellosis |
6 |
3 |
2 |
|
Shigellosis |
0 |
0 |
0 |
|
Vibrio infection |
1 |
0 |
0 |
|
Yersiniosis |
0 |
1 |
0 |
|
VIRAL HEPATIDES: |
|
|
|
|
Hepatitis A |
0 |
1 |
1 |
|
Hepatitis B (acute & non-acute) |
7 |
13 |
5 |
|
INVASIVE DISEASES: |
|
|
|
|
Legionellosis |
0 |
0 |
0 |
|
Streptococcal Group A, invasive |
1 |
1 |
0 |
|
Streptococcal Group B, invasive, infant <90 days |
0 |
0 |
0 |
|
Streptococcus pneumoniae, invasive |
4 |
4 |
2 |
|
VECTOR-BORNE & ZOONOTIC DISEASES: |
|
|
|
|
Chikungunya |
0 |
0 |
0 |
|
Dengue |
0 |
0 |
0 |
|
Hantavirus infection |
0 |
0 |
0 |
|
West Nile virus |
0 |
0 |
0 |
|
Zika |
0 |
0 |
0 |
|
ALSO OF INTEREST IN ARIZONA: |
|
|
|
|
Candida auris |
2 |
1 |
0 |
|
Carbapenem-resistant Enterobacteriaceae (CRE) |
1 |
4 |
3 |
|
Coccidioidomycosis |
24 |
24 |
25 |
|
Mpox |
0 |
0 |
0 |
1Data are provisional and reflect case reports to Mohave County Department of Public Health during this period.
2These counts reflect the date reported or tested and not necessarily the date infected.
3The 5-year median includes cases reported 2018-2022; novel coronavirus uses a 3-year median, 2020-2022
Updated 04/25/2023